Finally, we performed exploratory post-hoc comparisons within the CAA group, comparing those with amyloid-PET positive and negative scans, and found that those who were PET positive showed differences in Aβ42, t-tau, p-tau, NFL, and neurogranin, in an AD-like profile. This evidence concerns the gene MAPT and Alzheimer disease.